糖尿病视网膜病变的诊断和治疗的新基因标
Emine Çinici1, Mehmet Enes Arslan2, Özge Çağlar Yıldırım2
1Department of Ophthalmology, Atatürk University Faculty of Medicine, Erzurum, Türkiye.
The Eurasian journal of medicine
|May 16, 2025
概括
新的基因标SERPING1和IGFBP3显示出早期糖尿病视网膜病变 (DR) 诊断和治疗的前景. 这些基因通过对患有糖尿病 (DM) 和DR的患者的外周血液单核细胞的分析来确定.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病视网膜病变 (DR) 是糖尿病 (DM) 的主要并发症,由于视网膜神经和血管功能障碍,导致逐渐视力丧失.
- 现有的DR治疗方法和诊断方法存在局限性,突出显示需要新的治疗和预后目标.
- 识别特定的遗传标记可以显著改善DR的早期检测和管理.
研究的目的:
- 确定用于糖尿病视网膜病变 (DR) 的预后和治疗的新型基因标.
- 分析候选基因的表达模式在DR患者,没有DR的DM和健康对照中.
主要方法:
- 使用SYBR-Green的实时聚合酶链反应 (PCR) 用于分析外围血液单核细胞 (PBMC) 中的八个候选基因.
- 参与者包括45人,15人患有DR,15人患有DM但没有DR,15人健康对照.
- 使用STRING v11进行了蛋白质-蛋白质相互作用分析,并使用ANOVA (P < .05) 评估基因表达差异.
主要成果:
- 与对照组相比,在DR和DM组中,HIF1A和VEGFA的调节升高.
- 特别是在DR患者中,SERPING1的调高显著.
- 在DR和DM组中,CX3CR1和BDNF的下调,而IGFBP3仅在DR患者中显著下调. 字符串分析将SERPING1与补充通路,IGFBP3与胰岛素类生长因子信号联系起来.
结论:
- 基因SERPING1和IGFBP3显示出作为糖尿病视网膜病变 (DR) 早期诊断的新生物标志物的潜力.
- 这些基因也可以作为治疗点来管理DR.
- 需要进一步的研究来验证这些发现并探索它们的临床实用性.
更多相关视频
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
13.1K
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
995
相关概念视频
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...